CEO Christopher Reedy discloses ongoing cancer treatment; remains in role

BUTLER NATIONAL CORP

CEO Christopher Reedy informed employees of new medical treatment following Mayo Clinic consultations; he has continued follow-ups since 2019 cancer diagnosis.
Reedy will continue as CEO and remain actively engaged with operations, leadership team, and Board.
Executive Chairman Jeffrey D. Yowell and Lead Independent Director Joseph P. Daly expressed full Board support for Reedy.
Treatment may periodically require time away from office; executive leadership team and Board will support ongoing operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.